Page last updated: 2024-11-02

oxymetazoline and Diabetic Retinopathy

oxymetazoline has been researched along with Diabetic Retinopathy in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalez-Saldivar, G1
Pita-Ortiz, IY1
Flores-Villalobos, EO1
Jaurrieta-Hinojos, JN1
Espinosa-Soto, I1
Rios-Nequis, G1
Ramirez-Estudillo, A1
Jimenez-Rodriguez, M1

Other Studies

1 other study available for oxymetazoline and Diabetic Retinopathy

ArticleYear
Oxymetazoline: reduction of subconjunctival hemorrhage incidence after intravitreal injections.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2019, Volume: 54, Issue:4

    Topics: Adrenergic alpha-Agonists; Aged; Conjunctiva; Conjunctival Diseases; Diabetic Retinopathy; Double-Bl

2019